Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- March 7, 2017
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal